Singapore’s co-developed vaccine candidate is in ‘good shape’ for delivery in 2021 November 27, 2020 Business News Business Positive results were announced by Singapore's Covid vaccine candidate ARCT-021, developed by Arcturus Therapeutics together with Duke-NUS Medical School. With thanks to our Friends over at : Business News Read the Full Story : Click here